Better Coronavirus Stock: Moderna vs. Pfizer

Keith Speights, The Motley Fool
·4 min read
Better Coronavirus Stock: Moderna vs. Pfizer
Better Coronavirus Stock: Moderna vs. Pfizer

Only two coronavirus vaccines have a realistic possibility of becoming available by the end of 2020. Moderna (NASDAQ: MRNA) makes one of the vaccine candidates in the running. While Moderna and Pfizer share this one important thing in common, the two drugmakers are quite different in many respects.